Search Results - "antipsychotic"

High‐dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital by Yuji Yamada, Yuma Yokoi, Zui Narita, Naotsugu Hirabayashi

Connect to this object online.

The Effectiveness of Lurasidone Add-On for Residual Aggressive Behavior and Obsessive Symptoms in Antipsychotic-Treated Children and Adolescents with Tourette Syndrome: Preliminary Evidence from a Case Series by Marco Colizzi, Riccardo Bortoletto, Leonardo Zoccante

Connect to this object online.

Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data by Rashmi Patel, Aimee Brinn, Jessica Irving, Jaya Chaturvedi, Shanmukha Gudiseva, Christoph U. Correll, Paolo Fusar-Poli, Philip McGuire

Connect to this object online.

Perospirone, a Novel Antipsychotic Drug, Inhibits Marble-Burying Behavior via 5-HT1A Receptor in Mice: Implications for Obsessive-Compulsive Disorder by Michihiko Matsushita, Nobuaki Egashira, Satoko Harada, Ryoko Okuno, Kenichi Mishima, Katsunori Iwasaki, Ryoji Nishimura, Michihiro Fujiwara

Connect to this object online.

Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials by Sara Palermo, Sara Palermo, Fabio Giovannelli, Massimo Bartoli, Martina Amanzio, Martina Amanzio

Connect to this object online.

Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication) by Jun Ishigooka, Tomohiro Usami, Shuichi Iwashita, Yoshitsugu Kojima, Satoshi Matsuo

Connect to this object online.

Cognitive functions following initiation of antipsychotic medication in adolescents and adults at clinical high risk for psychosis: a naturalistic sub group analysis using the MATRICS consensus cognitive battery by TianHong Zhang, YanYan Wei, XiaoChen Tang, HuiRu Cui, LiHua Xu, YeGang Hu, YingYing Tang, Qiang Hu, HaiChun Liu, ZiXuan Wang, Tao Chen, ChunBo Li, JiJun Wang

Connect to this object online.

Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D2 Receptor by Rafaela R. Silva, Lucas T. Parreiras-, Thais E.T. Pompeu, Diego A. Duarte, Carlos A.M. Fraga, Eliezer J. Barreiro, Ricardo Menegatti, Claudio M. Costa-Neto, François Noël

Connect to this object online.

Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study by Charmi Patel, Seth Emont, Zhun Cao, Manu Tyagi, Carmela Benson

Connect to this object online.

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors by Richard G.W. Proudman, Juliana Akinaga, Jillian G. Baker

Connect to this object online.

Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study by Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García, Luis Alberto Forcen-Muñoz, Santiago Ovejero García, Rocío Sáez Povedano, Ana Luisa González-Galdámez, Laura Mata Iturralde, Fernando Hernández-Sánchez, Mariluz Ramirez Bonilla, Paloma Fuentes-Pérez, Claudia Ovejas-Catalán, Paula Suárez-Pinilla, Francisco Valdivia-Muñoz, Blanca Fernández Abascal, Miguel Omaña Colmenares, Ángela de Lourdes Martín-Pérez, María Pilar Campos-Navarro, Enrique Baca-García, Sergio Benavente-López, Alberto Raya Platero, Miguel Barberán Navalón, Sergio Sánchez-Alonso, Javier Vázquez-Bourgon, Sofia Pappa

Connect to this object online.

A randomized controlled study to evaluate the effects of lifestyle intervention program for patients with severe mental illness taking Second Generation Antipsychotics (SGAs) in body weight management and monitoring their Body Mass Index (BMI) by Daniel Yung-fai Cho, Kwan-tai Leung, Fanny So-man Ip, Kei-man Ng, Wing-sum Yuen, Ka-yan Lai, Wanda Luen-wun Siu

Connect to this object online.

A randomized controlled study to evaluate the effects of lifestyle intervention program for patients with severe mental illness taking Second Generation Antipsychotics (SGAs) in body weight management and monitoring their Body Mass Index (BMI) by Daniel Yung-fai Cho, Kwan-tai Leung, Fanny So-man Ip, Kei-man Ng, Wing-sum Yuen, Ka-yan Lai, Wanda Luen-wun Siu

Connect to this object online.

Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson’s Disease Psychosis by Rajagopalan K, Rashid N, Yakkala V, Doshi D

Connect to this object online.

A randomized controlled study to evaluate the effects of lifestyle intervention program for patients with severe mental illness taking Second Generation Antipsychotics (SGAs) in body weight management and monitoring their Body Mass Index (BMI) by Daniel Yung-fai Cho, Kwan-tai Leung, Fanny So-man Ip, Kei-man Ng, Wing-sum Yuen, Ka-yan Lai, Wanda Luen-wun Siu

Connect to this object online.

A randomized controlled study to evaluate the effects of lifestyle intervention program for patients with severe mental illness taking Second Generation Antipsychotics (SGAs) in body weight management and monitoring their Body Mass Index (BMI) by Daniel Yung-fai Cho, Kwan-tai Leung, Fanny So-man Ip, Kei-man Ng, Wing-sum Yuen, Ka-yan Lai, Wanda Luen-wun Siu

Connect to this object online.

A randomized controlled study to evaluate the effects of lifestyle intervention program for patients with severe mental illness taking Second Generation Antipsychotics (SGAs) in body weight management and monitoring their Body Mass Index (BMI) by Daniel Yung-fai Cho, Kwan-tai Leung, Fanny So-man Ip, Kei-man Ng, Wing-sum Yuen, Ka-yan Lai, Wanda Luen-wun Siu

Connect to this object online.

Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020 by Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak

Connect to this object online.

Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, subsequent acute care use and effectiveness of medication to which patients switched by Rollo J.G. Sheldon, Marco Pereira, George Aldersley, Tim Sales, Jed Hewitt, Ray Lyon, Richard Whale

Connect to this object online.

Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' Pharmacare Program and Canadian Institute for Health's Discharge Databases by Shanna C. Trenaman, MAHSR, ACPR, Barbara J. Hill-Taylor, MLIS, Kara J. Matheson, MSc, David M. Gardner, PharmD, MSc, Ingrid S. Sketris, PharmD, MPA (HSA)

Connect to this object online.